Case report: The histopathological analyses of two myelin oligodendrocyte glycoprotein antibody-associated diseases with a distinctive linear radiating gadolinium enhancement on MRI

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) has highly heterogeneous clinical presentations, in which encephalitis is an important phenotype. Moreover, MOGAD has been reported to exhibit diverse imaging findings. However, there have been no previous reports of cases with...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 15; p. 1426236
Main Authors Shimizu, Mikito, Beck, Goichi, Murayama, Shigeo, Hoshi, Taku, Sumikura, Hiroyuki, Higashida, Kyoko, Fukasaka, Isao, Shimada, Yuki, Nagashima, Nozomi, Fujioka, Tomohiro, Hatayama, Naoki, Okuno, Tatsusada, Mochizuki, Hideki, Sakaguchi, Manabu
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 29.08.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) has highly heterogeneous clinical presentations, in which encephalitis is an important phenotype. Moreover, MOGAD has been reported to exhibit diverse imaging findings. However, there have been no previous reports of cases with perivascular radial gadolinium enhancement in periventricular regions, commonly reported in autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy. In this paper, we present two cases of MOGAD with this MRI feature, both of which underwent brain biopsy for the lesions. Brain biopsies revealed perivenous demyelination and inflammation consistent with acute disseminated encephalomyelitis (ADEM), with pronounced axonal damage in Case 1 and minimal axonal involvement in Case 2. Case 1 exhibited more severe cerebral atrophy than Case 2, correlating with the extent of axonal damage. Through these cases, we highlight the heterogeneity of radiological manifestations of MOGAD, expanding the spectrum beyond previously defined MRI patterns. Furthermore, histopathological analysis revealed distinct axonal involvement as a potential prognostic marker of brain atrophy. These observations emphasize the importance of considering MOGAD in the differential diagnosis, even in cases with atypical imaging findings, and highlight the significance of brain biopsy in guiding both diagnosis and prognosis.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
Silvia Noemi Tenembaum, Garrahan Hospital, Argentina
Edited by: Matteo Foschi, Azienda Unità Sanitaria Locale (AUSL) della Romagna, Italy
Reviewed by: Youming Long, The Second Affiliated Hospital of Guangzhou Medical University, China
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2024.1426236